Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N’Djamena, Chad: findings from a cross-sectional study

Table 2 Virological failure per antiretroviral regimens

Treatment regimens	Patients per regimen	Virological failure per regimen, n (%)
AZT+3TC+NVP	53	19 (35.85%)
d4T+3TC+NVP	48	23 (47.92%)
FTC+TDF+EFV	13	6 (46.15%)
ABC+3TC+EFV	1	1 (100%)
ABC+3TC+EFV	1	1 (100%)

Italic value indicates the most prescribed antiretroviral regimen
ABC Abacavir, AZT Zidovudine, 3TC lamuvidine, EFV efavirenz, NVP nevirapine, d4T stavudine, TDF tenofovir, FTC emtricitabine

ISSN: 1756-0500